For security purposes
FOR SECURITY PURPOSES - because Internet Explorer is no longer supported by Microsoft, we suggest that you interact with our secure site through one of our supported browsers - Google Chrome, Firefox, or MS Edge. If you continue to use this website with Internet Explorer you do so at your own risk and you may encounter problems.
Applications
Morphine and Metabolites on Synergi Polar-RP (direct injection after PPT)
16446
Separation Mode: Reversed Phase
Reversed Phase
Polar-RP
HPLC
Central Nervous System Stimulants
Pharmaceutical
Therapeutic / Clinical

Applications

Morphine and Metabolites on Synergi Polar-RP (direct injection after PPT)
Analytes
1Morphine
2Normorphine
3Morphine-3-beta-D-glucuronide
Compound Name
Morphine
CID
5288826
Molecular Formula
C17H19NO3
Molecular Weight
285
No. Hydrogen Bond Acceptors
4
No. Hydrogen Bond Donors
2
Details
LC Conditions (App ID: 16446)
Column:
Brand Name:
Part No:
Phase Name:
Polar-RP
Elution Type:
Gradient
Mobile Phase:
A: 0.1% Formic Acid in Water
B: 0.1% Formic Acid in Acetonitrile
Gradient Profile:
Step No.Time(min)%A%B
10973
22973
34.85050
Flow Rate:
0.4 mL/min
Temperature:
22°C
Detection:
Mass Spectrometer (MS) (22°C)
Detector Info:
following 5:1 Acetonitrile/Water PPT, direct injection
Sample Note:
SecurityGuard™ Guard Cartridge System extends column lifetime. - SecurityGuard Cartridges, POLAR-RP 4 x 2.0mm, 10/Pk Part No.: AJ0-6075 - Holder Part No.: KJ0-4282

Order Items Used in This Application

Similar Applications
search
No Data